A study published in JAMA Psychiatry raises questions about how people interpret the Patient Health Questionnaire (PHQ), a screening tool used since the 1990s and mandated by agencies such as the National Institutes of Health. The research was led by Zachary Cohen, an assistant professor at the University of Arizona.
About 850 participants completed a PHQ and then read a hypothetical scenario: oversleeping nearly every day for a week but not feeling bothered, for example on vacation. Responses were inconsistent: only 328 participants (38%) chose "not at all" in that scenario. Only 146 participants (17%) said they would answer future PHQs based on how much symptoms "bother" them rather than only on frequency.
The authors warn that this inconsistency can produce misleading data. They give examples such as passive sleep data from smartwatches conflicting with PHQ answers, or appetite changes from drugs like Ozempic being misread as depression if the "bothered by" element is ignored. They recommend changing PHQ wording to separate frequency from distress and call for further studies to test those changes.
Difficult words
- mandate — officially require something by law or rulemandated
- hypothetical — imagined for discussion or for testing
- inconsistent — not the same in every case
- misleading — giving the wrong idea or impression
- distress — strong worry or emotional pain
- oversleep — sleep more than usual or intendedoversleeping
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Should health questionnaires ask about both how often symptoms happen and how much they bother someone? Why or why not?
- What problems could appear if smartwatch data and questionnaire answers do not match?
- If you filled a questionnaire like the PHQ, would you answer based on frequency or how much symptoms bother you? Explain your choice.
Related articles
Wearable 10‑Minute Antibody Sensors from University of Pittsburgh
Researchers at the University of Pittsburgh made a wearable biosensor that detects antibodies in interstitial fluid in 10 minutes without a blood draw. The tiny carbon nanotube sensors are highly sensitive and the work appears in Analytical Chemistry.
Most US drug trials do not mirror racial and ethnic diversity
A study of pivotal trials used to approve new drugs found only a small share reflect the United States racial and ethnic makeup. The review shows underrepresentation of Black and Hispanic people and urges more diversity earlier in development.
Tool that Reorders X Feed Reduces Partisan Rancor
Researchers built a browser extension that scans an X feed for antidemocratic and partisan posts and reorders them without removing content or platform cooperation. Tests during the 2024 election showed small but measurable improvements in attitudes toward the other party.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.